Travocor 0.004% Eye Drop
By Travocor
Rx
3ml Eye Drop in a Bottle

Composition
Travoprost(0.004% w/v)

Manufacturer - Choroid Laboratories
Surya Nagar Market, Vikhroli (West), Mumbai, Maharashtra, INDIA

Expires on or after
September, 2025

liver
Travocor 0.004% Eye Drop is deemed safe for individuals with liver diseases or conditions when recommended by a healthcare provider. It is essential for patients with liver issues to follow their doctor's advice before using this eye drop. There have been no interactions identified between the eye drop and liver concerns. Please consult with your doctor for proper guidance before using Travocor 0.004% Eye Drop.

kidney
Travocor 0.004% Eye Drop is safe for patients with kidney conditions if doctor-prescribed. No interactions have been found.

alcohol
No interaction is known between alcohol and Travocor 0.004% Eye Drop. It is recommended to either avoid or reduce alcohol consumption as a precautionary step.

driving
When using Travocor 0.004% Eye Drop, it's important to note that it usually doesn't impact your driving ability. However, Travotas 0.004% Eye Drop 3 ml can cause temporary blurred vision. Avoid driving or activities requiring clear vision after using this drop.

pregnancy
Travocor 0.004% Eye Drop may not be safe to use during pregnancy due to potential harmful effects on the developing baby based on animal studies. Your doctor will assess the benefits and risks before prescribing it. Consult your doctor before using during pregnancy.

breastfeeding
Travocor 0.004% Eye Drop should be used cautiously if you are breastfeeding. It is advised to wait until the mother's treatment is finished and the drug is cleared from her system. Your doctor will assess the benefits and risks before recommending Travotas 0.004% Eye Drop 3 ml for breastfeeding women.
Habit Forming | No |
Chemical Class | Prostaglandin analogue |
Therapeutic Class | - |
Action Class | PG F2 Alpha analogue |
₹179
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024